Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
---|---|---|---|---|
Total Revenue | -- | 19,647 | 1,082 | 1,213 |
Cost of Revenue | -- | -- | -- | (33,084) |
Gross Profit | 417 | 19,647 | 1,082 | 1,213 |
Operating Expenses | ||||
Research Development | 175 | 4,668 | (5,531) | 7,007 |
Selling General and Administrative | 1,111 | 1,310 | -- | 1,626 |
Non Recurring | -- | -- | -- | -- |
Others | 0 | 0 | (1,814) | 0 |
Total Operating Expenses | 1,286 | 5,978 | (7,345) | 8,633 |
Operating Income or Loss | (869) | 13,669 | 6,613 | (7,420) |
Income from Continuing Operations | ||||
Total Other Income/Expenses Net | (26) | (26) | (25) | (25) |
Earnings Before Interest And Taxes | (869) | 13,698 | 6,665 | (7,395) |
Interest Expense | -- | -- | -- | -- |
Income Before Tax | (842) | 13,698 | 6,665 | (7,249) |
Income Tax Expense | -- | -- | -- | (435) |
Minority Interest | -- | -- | -- | -- |
Net Income From Continuing Ops | (83) | 12,144 | 6,665 | (6,387) |
Non-recurring Events | ||||
Discontinued Operations | -- | -- | -- | -- |
Extraordinary Items | -- | -- | -- | -- |
Effect Of Accounting Changes | -- | -- | -- | -- |
Other Items | 0 | 0 | 0 | 0 |
Net Income | (83) | 12,144 | 6,665 | (6,387) |
Preferred Stock And Other Adjustments | (759) | 1,554 | 605 | -- |
Net Income Applicable To Common Shares | (83) | 12,144 | 6,060 | (6,387) |